论文部分内容阅读
目的：观察输自体血和异体血对乳腺癌病人术后生存率的影响，并了解其是否可能传播血源性传染性疾病。方法：依照国际乳腺癌TNM分期标准，选择100例Ⅰ～Ⅱ期乳腺癌患者，分成自体输血组和异体输血组，每组50例。自体输血是指术前一天采自体血200～400ml，于术中回输给病人；异体输血是指术中输库存异体血。对比观察术中血压、脉博情况和不良输血反应，并对术后病人进行随防。结果：自体输血组术中血压、脉搏平稳，术中无输血反应，术后无血源性传染疾病发生，术后1年、3年生存率明显高于异体输血组。结论：自体输血可避免血源性传染病的发生，延长患者生存时间。
Objective: To observe the effect of blood transfusion and allogeneic blood on the postoperative survival rate of breast cancer patients, and to understand whether it is possible to spread blood-borne infectious diseases. METHODS: According to the international breast cancer TNM staging criteria, 100 patients with stage I to stage II breast cancer were selected and divided into autologous transfusion group and allogeneic transfusion group, 50 cases in each group. Autologous blood transfusion refers to 200-400 ml of blood taken from the day before surgery, which is returned to the patient during surgery. Allogeneic blood transfusion refers to intraoperative loss of allogeneic blood. Contrast observation of intraoperative blood pressure, pulse conditions, and adverse blood transfusion reactions, and follow-up of patients after surgery. RESULTS: Autologous blood transfusion group had stable blood pressure and pulse during operation, no blood transfusion reaction during operation, and no postoperative blood-borne infectious disease. The 1-year and 3-year survival rates were significantly higher than those of allogeneic blood transfusion group. Conclusion: Autologous blood transfusion can avoid the occurrence of blood-borne infectious diseases and prolong the survival time of patients.